RAPID CITY, S.D. (KOTA) – A new clinical trial conducted by the American Indian Clinical Trials Research Network in Rapid City will test a new drug to treat diabetic peripheral neuropathy.
According to the American Diabetes Association: More than 10% of South Dakota adults have diabetes.Some people with diabetes suffer from conditions such as diabetic peripheral neuropathy, which causes numbness and pain in the hands and feet. If the trial shows promising results, the study could become an important topic of medical research.
“If Phase 2 is successful, the drug could move on to Phase 3 trials and be administered globally to tens of thousands of subjects at sites around the world,” said Dr. Jeffrey Henderson, principal investigator of the American Indian Clinical Trials Research Network.
Henderson said phase one testing in animals had gone well.
In the second phase, human patients will take the oral medication and report back on their results.Henderson explained that although his clinic bears the name “American Indian” and he often works with Native Americans, the trial is open to qualified diabetes patients of any race or ethnicity.
People interested in participating in the study should call the American Indian Clinical Trials Research Network at (605) 939-3686.
Did you notice any spelling or grammar mistakes in the article? click here I will report it.
Have photos or videos of breaking news? Send it here Comes with a brief explanation.
Copyright 2024 KOTA. Unauthorized reproduction prohibited.
